CTU Bern (Clinical Trials Unit)

Declaration of Interest

CTU Bern, including CTU Bern staff, aims at being independent of financially driven biases. CTU Bern acknowledges that clinical research is costly and some research would not be possible without financial support from organizations that have a vested interest (non-financial interests are not covered herein) in the results of the research they support. Therefore, CTU Bern aims at transparency and minimizing financial biases.

CTU Bern has a funding policy that is binding to all staff.

Funding of clinical studies

CTU Bern may be involved in studies that are funded by for-profit organizations with a commercial interest in healthcare. However, CTU Bern ensures transparent reporting of funding sources and endorses access to all study data by academic researchers and unbiased and unrestricted publication of study results. CTU Bern is and will not be involved in any clinical study (co-)funded by the tobacco industry.

List of funding sources

Only major projects listed

CTUPP Nr.   
Name Funding
0458 BIOSTEMI Biotronik AG
0533 OPTICO BVS St. Jude Medical
0453 TOLERANT Bayer (Schweiz) AG
0428 BEB EMPIRIS
Mundipharma Medical Company
0536 SAAL Miltenyi Biotec GmbH
0441 MDS Registry Novartis Pharma Schweiz AG
Celgene GmbH
0468 OSCAR GALILEO Bayer AG
0415 OPERAM EU Horizon2020
0628 SCOPE I Symetis SA
0670 DAWN2 CH Novo Nordisk AG
0640 NOSTONE SNF
0679 ELAN SNF
0677 Simpl'HIV trial SNF
0689 H-PACS Lifecell
0634 MASTER DAPT
Terumo Medical Corporation
0636 SERVE SNF
0632 SYMPTOM NAVI Pilot Stiftung Lindenhof Bern
0613 SCRIPT University of Bern
0606 REVEAL in TAVI
SNF
Medtronic (Schweiz) AG